As the death toll from Ebola rises in West Africa, U.S. government researchers are working hard to get experimental flu drugs from such companies as Tekmira Pharmaceuticals Corp. and Fujifilm Holdings Corp. quickly approved to treat it.
Vancouver-based Tekmira Pharmaceuticals said U.S. regulators have paved the way for the company to possibly give its experimental Ebola drug to people infected with the deadly disease, which has no cure.
The U.S. Food and Drug Administration had previously put tests of the drug, known as TKM-Ebola, on hold. The company said the agency altered the therapy's status to possibly allow its use in those infected with the virus that has killed 932 people in West Africa since March.